Search Results - "Snyder, D L"

Antibody Desensitization Therapy in Highly Sensitized Lung Transplant Candidates by Snyder, L. D., Gray, A. L., Reynolds, J. M., Arepally, G. M., Bedoya, A., Hartwig, M. G., Davis, R. D., Lopes, K. E., Wegner, W. E., Chen, D. F., Palmer, S. M.

“…As HLAs antibody detection technology has evolved, there is now detailed HLA antibody information available on prospective transplant recipients. Determining…”
Get full text

Colonization With Small Conidia Aspergillus Species Is Associated With Bronchiolitis Obliterans Syndrome: A Two‐Center Validation Study by Weigt, S. S., Copeland, C. A. Finlen, Derhovanessian, A., Shino, M. Y., Davis, W. A., Snyder, L. D., Gregson, A. L., Saggar, R., Lynch, J. P., Ross, D. J., Ardehali, A., Elashoff, R. M., Palmer, S. M., Belperio, J. A.

“…Aspergillus colonization after lung transplantation may increase the risk for bronchiolitis obliterans syndrome (BOS), a disease of small airways. We…”
Get full text

Spirometrically Significant Acute Rejection Increases the Risk for BOS and Death After Lung Transplantation by Davis, W. A., Finlen Copeland, C. A., Todd, J. L., Snyder, L. D., Martissa, J. A., Palmer, S. M.

“…Acute rejection (AR) is a common complication following lung transplantation and is an established risk factor for bronchiolitis obliterans syndrome (BOS). AR…”
Get full text

Epithelial Clara Cell Injury Occurs in Bronchiolitis Obliterans Syndrome After Human Lung Transplantation by Kelly, F. L., Kennedy, V. E., Jain, R., Sindhwani, N. S., Finlen Copeland, C. A., Snyder, L. D., Eu, J. P., Meltzer, E. B., Brockway, B. L., Pavlisko, E., Stripp, B. R., Palmer, S. M.

“…Bronchiolitis obliterans syndrome (BOS) is a condition of progressive airflow obstruction that affects a majority of lung transplant recipients and limits…”
Get full text

Significance of and Risk Factors for the Development of Central Airway Stenosis After Lung Transplantation by Shofer, S. L., Wahidi, M. M., Davis, W. A., Palmer, S. M., Hartwig, M. G., Lu, Y., Snyder, L. D.

“…Central airways stenosis (CAS) after lung transplant is a poorly understood complication. Objectives of this study were to determine if CAS was associated with…”
Get full text

Is Prevention the Best Treatment? CMV After Lung Transplantation by Patel, N., Snyder, L. D., Finlen Copeland, C. A., Palmer, S. M.

“…Cytomegalovirus (CMV) is the most prevalent opportunistic infection that occurs in lung‐transplant recipients. In addition to its direct morbidity, multiple…”
Get full text

Genetic Regulation of Rejection and Survival Following Human Lung Transplantation by the Innate Immune Receptor CD14 by Palmer, S. M., Klimecki, W., Yu, L., Reinsmoen, N. L., Snyder, L. D., Ganous, T. M., Burch, L., Schwartz, D. A.

“…We have developed the hypothesis that genetic polymorphisms which alter the expression or function of innate immune receptors contribute to the marked…”
Get full text

Polyfunctional Cytomegalovirus‐Specific Immunity in Lung Transplant Recipients Receiving Valganciclovir Prophylaxis by Snyder, L. D., Medinas, R., Chan, C., Sparks, S., Davis, W. A, Palmer, S. M., Weinhold, K. J.

“…Cytomegalovirus (CMV) is a common opportunistic infection after lung transplant. Despite effective antiviral medications to treat CMV, invasive CMV disease…”
Get full text

Staging of Bilateral Lung Transplantation for High‐Risk Patients With Interstitial Lung Disease: One Lung at a Time by Hartwig, M. G., Ganapathi, A. M., Osho, A. A., Hirji, S. A., Englum, B. R., Speicher, P. J., Palmer, S. M., Davis, R. D., Snyder, L. D.

“…The choice of a single or bilateral lung transplant for interstitial lung disease (ILD) is controversial, as surgical risk, long‐term survival and organ…”
Get full text

Alemtuzumab in the Treatment of Refractory Acute Rejection and Bronchiolitis Obliterans Syndrome After Human Lung Transplantation by Reams, B. D., Musselwhite, L. W., Zaas, D. W., Steele, M. P., Garantziotis, S., Eu, P. C., Snyder, L. D., Curl, J., Lin, S. S., Davis, R. D., Palmer, S. M.

“…Despite substantial improvements in early survival after lung transplantation, refractory acute rejection (RAR) and bronchiolitis obliterans syndrome (BOS)…”
Get full text

Iterative deblurring for CT metal artifact reduction by Ge Wang, Snyder, D.L., O'Sullivan, J.A., Vannier, M.W.

“…Iterative deblurring methods using the expectation maximization (EM) formulation and the algebraic reconstruction technique (ART), respectively, are adapted…”
Get full text

Five Year Follow-Up of Staged Bilateral Lung Transplantation for High-Risk Patients with Interstitial Lung Disease: A Matched Case-Control Study by Choi, A.Y., Raman, V., Jawitz, O.K., Halpern, S.E., Bryner, B.S., Snyder, L.D., Hartwig, M.G.

“…The choice of single (SOLT) or bilateral orthotopic lung transplant (BOLT) for interstitial lung disease (ILD) remains controversial. Our center adopted a…”
Get full text

NanoString Gene Expression Profiling in Chronic Lung Allograft Dysfunction (CLAD) by Todd, J.L., Kelly, F.L., Neely, M.L., Keslar, K., Pavlisko, E.N., McCall, S.J., Fletcher, A., Chen, X., Frankel, C.W., Singer, L.G., Budev, M., Shah, P.D., Belperio, J.A., Snyder, L.D., Reynolds, J.M., Fairchild, R.L., Palmer, S.M.

“…CLAD, mainly manifest as bronchiolitis obliterans syndrome (BOS), is the leading cause of late death in lung recipients. BOS develops despite routine…”
Get full text

A Multi-Center Study of BAL CXCR3 Chemokines during Allograft Injury after Lung Transplantation by Shino, M.Y., Elashoff, R.M., Li, N., Todd, J.L., Neely, M.L., Kopetskie, H., Sever, M., Kirchner, J., Frankel, C.W., Snyder, L.D., Pavlisko, E.N., Martinu, T., Singer, L.G., Tsuang, W., Budev, M., Shah, P.D., Williams, N., Robien, M., Reynolds, J.M., Palmer, S.M., Weigt, S.S., Belperio, J.A.

“…The occurrence of acute allograft injuries remains one of the most important factors responsible for the development of early chronic lung allograft…”
Get full text

Agreement between Fried Frailty Phenotype and Cumulative Deficits Frailty Indices: A Prospective Multi-Center Study by Rozenberg, D., Singer, L.G., Neely, M.L., Weber, J.M., Kopetskie, H.A., Sever, M.L., Kirchner, J., Frankel, C.W., Todd, J.L., Williams, N., Robien, M.A., Belperio, J., Budev, M.M., Tsuang, W., Reynolds, J.M., Turner, D., Shah, P.D., Palmer, S.M., Snyder, L.D.

“…Frailty is gaining increased recognition in the evaluation of lung transplant (LTx) candidates. The Fried Frailty Phenotype (FFP) index has been the most…”
Get full text

Prospective Assessment of Chronic Lung Allograft Dysfunction (CLAD); the Clinical Trials in Organ Transplantation (CTOT) Study Experience by Frankel, C.W., Kopetskie, H., Sever, M., Cosgrove, M., Kirchner, J., Robien, M., Williams, N., Reynolds, J.M., Arroyo, K., Shah, P., Mathew, J., Budev, M.M., Maierson, E., Singer, L.G., Islam, A., Belperio, J.A., Weigt, S.S., Punzalan, E., Neely, M., Todd, J.L., Snyder, L.D., Palmer, S.M.

“…Diagnosis of CLAD after lung transplantation (LT) requires sustained decline in lung function and exclusion of other etiologies for the decline. The…”
Get full text

Protein Quantitative Trait Loci Analysis Identifies Genetic Variation in the Innate Immune Regulator TOLLIP in Post–Lung Transplant Primary Graft Dysfunction Risk by Cantu, E., Suzuki, Y., Diamond, J. M., Ellis, J., Tiwari, J., Beduhn, B., Nellen, J. R., Shah, R., Meyer, N. J., Lederer, D. J., Kawut, S. M., Palmer, S. M., Snyder, L. D., Hartwig, M. G., Lama, V. N., Bhorade, S., Crespo, M., Demissie, E., Wille, K., Orens, J., Shah, P. D., Weinacker, A., Weill, D., Wilkes, D., Roe, D., Ware, L. B., Wang, F., Feng, R., Christie, J. D.

“…The authors previously identified plasma plasminogen activator inhibitor‐1 (PAI‐1) level as a quantitative lung injury biomarker in primary graft dysfunction…”
Get full text

Lipopolysaccharide enhances bactericidal activity in Dictyostelium discoideum cells by Walk, Alexander, Callahan, Jennifer, Srisawangvong, Pat, Leuschner, Jessica, Samaroo, Dave, Cassilly, Daniel, Snyder, Michelle L.D.

“…Innate immune cells respond to invading microbes upon detection of pathogen-associated molecular patterns (PAMPS). PAMP-recognition machinery is evolutionarily…”
Get full text

Cobbling Together the Myddosome by Snyder, Michelle L.D., Snyder, Greg A.

“…An organism’s ability to recognize and respond quickly and appropriately to pathogenic stimuli is a fundamental aspect of innate immunity. Harnessing the…”
Get full text

The structure of NAD+ consuming protein Acinetobacter baumannii TIR domain shows unique kinetics and conformations by Klontz, Erik, Obi, Juliet O., Wang, Yajing, Glendening, Gabrielle, Carr, Jahid, Tsibouris, Constantine, Buddula, Sahthi, Nallar, Shreeram, Soares, Alexei S., Beckett, Dorothy, Redzic, Jasmina S., Eisenmesser, Elan, Palm, Cheyenne, Schmidt, Katrina, Scudder, Alexis H., Obiorah, Trinity, Essuman, Kow, Milbrandt, Jeffrey, Diantonio, Aaron, Ray, Krishanu, Snyder, Michelle L.D., Deredge, Daniel, Snyder, Greg A.

“…Toll-like and interleukin-1/18 receptor/resistance (TIR) domain–containing proteins function as important signaling and immune regulatory molecules. TIR…”
Get full text